Daniel Betticher

11.4k total citations
154 papers, 5.5k citations indexed

About

Daniel Betticher is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Daniel Betticher has authored 154 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 30 papers in Molecular Biology. Recurrent topics in Daniel Betticher's work include Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (18 papers). Daniel Betticher is often cited by papers focused on Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (18 papers). Daniel Betticher collaborates with scholars based in Switzerland, United States and United Kingdom. Daniel Betticher's co-authors include Jim Heighway, Daniel Ratschiller, Mathias Gugger, Markus Borner, Rolf A. Stahel, Oliver Gautschi, Didier Lardinois, Walter Weder, Андреас Каппелер and Roger Stupp and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel Betticher

151 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Betticher Switzerland 38 2.4k 2.2k 1.7k 850 833 154 5.5k
Yuankai Shi China 36 3.5k 1.4× 2.9k 1.3× 1.8k 1.1× 1.0k 1.2× 1.1k 1.3× 312 6.0k
Vivek Roy United States 40 2.4k 1.0× 1.5k 0.7× 2.9k 1.7× 702 0.8× 596 0.7× 203 6.1k
Victor M. Santana United States 43 2.0k 0.8× 1.4k 0.6× 2.0k 1.2× 479 0.6× 502 0.6× 148 5.4k
Steven G. DuBois United States 47 2.0k 0.8× 2.7k 1.2× 2.4k 1.5× 1.5k 1.8× 911 1.1× 281 7.4k
Siow Ming Lee United Kingdom 38 2.4k 1.0× 2.0k 0.9× 1.6k 0.9× 547 0.6× 366 0.4× 171 4.9k
Anil Potti United States 31 2.1k 0.9× 1.2k 0.5× 2.7k 1.6× 1.4k 1.7× 526 0.6× 103 5.3k
Jean‐Philippe Spano France 38 3.0k 1.2× 1.2k 0.5× 1.1k 0.7× 542 0.6× 639 0.8× 190 5.1k
Shenghui Tang United States 39 2.9k 1.2× 1.8k 0.8× 1.2k 0.7× 855 1.0× 432 0.5× 116 5.3k
Umberto Basso Italy 35 2.1k 0.9× 1.7k 0.8× 1.0k 0.6× 736 0.9× 295 0.4× 236 4.7k
Lia Gore United States 43 2.6k 1.0× 821 0.4× 2.6k 1.5× 632 0.7× 763 0.9× 202 6.1k

Countries citing papers authored by Daniel Betticher

Since Specialization
Citations

This map shows the geographic impact of Daniel Betticher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Betticher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Betticher more than expected).

Fields of papers citing papers by Daniel Betticher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Betticher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Betticher. The network helps show where Daniel Betticher may publish in the future.

Co-authorship network of co-authors of Daniel Betticher

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Betticher. A scholar is included among the top collaborators of Daniel Betticher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Betticher. Daniel Betticher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribi, Karin, Solange Peters, Markus Borner, et al.. (2021). Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment. Cancer Nursing. 44(6). E687–E702. 5 indexed citations
2.
Astaras, Christoforos, Adrienne Bettini, & Daniel Betticher. (2020). Response to Osimertinib in a Patient with Non-Small Cell Lung Cancer and Two Uncommon EGFR Mutations. SHILAP Revista de lepidopterología. 1 indexed citations
3.
4.
Curioni‐Fontecedro, Alessandra, Jean Yannis Perentes, Hans Gelpke, et al.. (2019). Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08). British Journal of Cancer. 120(10). 968–974. 5 indexed citations
5.
Novak, Urban, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, et al.. (2017). NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma. Bone Marrow Transplantation. 53(2). 175–179. 11 indexed citations
6.
Novak, Urban, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, et al.. (2016). BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients. Annals of Hematology. 96(3). 421–429. 25 indexed citations
7.
Baty, Florent, Oliver Dürr, Daniel Betticher, et al.. (2015). Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non–Small Cell Lung Cancer Patients (SAKK 19/05 trial). Clinical Cancer Research. 21(23). 5253–5263. 8 indexed citations
8.
9.
Samaras, Panagiotis, Mario Bargetzi, Daniel Betticher, et al.. (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly. 145(708). w14100–w14100. 4 indexed citations
10.
Betticher, Daniel, Geoffrey Delmore, Sandro Anchisi, et al.. (2013). Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Supportive Care in Cancer. 21(9). 2565–2573. 51 indexed citations
11.
Taverna, Christian, Mario Bargetzi, Daniel Betticher, et al.. (2010). Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations. Swiss Medical Weekly. 140(3738). w13054–w13054. 2 indexed citations
12.
Rothschild, Sacha I., Андреас Каппелер, Daniel Ratschiller, et al.. (2010). The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer. Lung Cancer. 71(3). 306–311. 26 indexed citations
13.
Pirnia, Farzaneh, Michael Pawlak, Gerhard Thallinger, et al.. (2009). Novel functional profiling approach combining reverse phase protein microarrays and human 3‐D ex vivo tissue cultures: Expression of apoptosis‐related proteins in human colon cancer. PROTEOMICS. 9(13). 3535–3548. 26 indexed citations
14.
Betticher, Daniel, et al.. (2008). Treatment in resectable, locally advanced NSCLC: which is the best approach?. Expert Review of Respiratory Medicine. 2(5). 655–661. 1 indexed citations
15.
Rohr, A. von, S.‐F. Hsu Schmitz, André Tichelli, et al.. (2002). Treatment of hairy cell leukemia with cladribine(2-chlorodeoxyadenosine) by subcutaneous bolus injection:a phase II study. Annals of Oncology. 13(10). 1641–1649. 37 indexed citations
16.
Vonlanthen, Silvia, Jim Heighway, H. J. Altermatt, et al.. (2001). The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. British Journal of Cancer. 84(10). 1372–1376. 245 indexed citations
17.
Gugger, Mathias, Андреас Каппелер, Silvia Vonlanthen, et al.. (2001). Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer. 33(2-3). 229–239. 28 indexed citations
18.
Laurencet, France M., et al.. (1999). Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. British Journal of Cancer. 79(7-8). 1215–1219. 43 indexed citations
19.
Furrer, Markus, Didier Lardinois, Wolfgang Thormann, et al.. (1998). Cytostatic Lung Perfusion by Use of an Endovascular Blood Flow Occlusion Technique. The Annals of Thoracic Surgery. 65(6). 1523–1528. 28 indexed citations
20.
Pugin, P, et al.. (1995). Erfolgreiche Behandlung eines Falls von kutaner Langerhanszell-Granulomatose mit 2-Chlorodesoxyadenosin und Thalidomid. Der Hautarzt. 46(8). 553–560. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuankai Shi Breakdown of academic impact, for papers by Vivek Roy Breakdown of academic impact, for papers by Victor M. Santana Breakdown of academic impact, for papers by Steven G. DuBois Breakdown of academic impact, for papers by Siow Ming Lee Breakdown of academic impact, for papers by Anil Potti Breakdown of academic impact, for papers by Jean‐Philippe Spano Breakdown of academic impact, for papers by Shenghui Tang Breakdown of academic impact, for papers by Umberto Basso Breakdown of academic impact, for papers by Lia Gore
Rankless by CCL
2026